Viracta Therapeutics, Inc. (VIRX) Financials

VIRX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 56.7 million 38.4 million
2023-09-30 66.4 million 36.4 million
2023-06-30 76.9 million 36.1 million
2023-03-31 85.8 million 34.7 million

VIRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -10.0 million 1.8 million
2023-09-30 -10.5 million 1.8 million
2023-06-30 -8.2 million 2.0 million
2023-03-31 -11.3 million 2.1 million

VIRX Net Income

No data available :(

VIRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 53.7 million - 282000
2023-09-30 63.0 million - 381000
2023-06-30 72.9 million - 475000
2023-03-31 80.3 million 22.8 million 563000

VIRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 38.8 million
2023-09-30 38.7 million
2023-06-30 38.6 million
2023-03-31 38.5 million

VIRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 9.4 million 4.2 million 123001
2023-09-30 51000 8.2 million 4.3 million -
2023-06-30 189000 8.2 million 4.3 million -
2023-03-31 189000 7.6 million 4.6 million -

VIRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 123000
2023-09-30 - 128000
2023-06-30 - 119000
2023-03-31 - 122000

VIRX

Price: $0.82

52 week price:
0.43
2.38

Earnings Per Share: -1.32 USD

P/E Ratio: -0.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 46946

Market Capitalization: 30.6 million

Links: